Philippe Deecke
Philippe Deecke is the Chief Financial Officer of Lonza, a prominent Swiss pharmaceutical and biotechnology company. Recently, he addressed financial analysts regarding the potential impact of imminent US tariffs on pharmaceuticals, assuring stakeholders that Lonza primarily serves American clients from its US operations and is well-positioned in the biopharmaceutical manufacturing sector.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 1 | 6.00 | 0.08% | +0% | 8,654,622 | 6,929 | $700,000 | 560$ |
| Totals | 1 | 8,654,622 | 6,929 | $700,000 | 560$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Philippe Deecke is the CFO of Lonza and commented on the impact of tariffs on generic drug providers.
6
Switzerland:
Philippe Deecke is the CFO of Lonza and expressed concerns about the financial capabilities of pharmaceutical companies.
5
Switzerland:
Philippe Deecke, the CFO of Lonza, addressed financial analysts regarding the company's operations in the US.
6